Andover Capital Partners
Andover Venture Fund I
Andover Capital Partners is the Manager of Andover Venture Fund I which has made early and expansion stage investments in privately-held Australian and U.S. technology companies. Integral to our investment approach is to leverage the investment team’s strong record in science and technology commercialization, extensive offshore networks, international business and investment banking experience.
- Sector Focus
- Clean Tech
- Information Technology
- Medical
- Investee Company Criteria
- Globally scalable businesses with strong competitive advantages
- Proven entrepreneurial management team committed to growth
- Proprietary technology, product or service with clear ownership of IP
- Early to middle life cycle stage preferred, start ups considered
- Businesses generating or having near term potential to generate high free cash flow
- Attractive valuation, investment and governance terms on entry
- Excellent prospects for exit via an IPO or business combination
- Investment Portfolio
- 3D Clinic Pty Limited (New South Wales)
- Agamatrix, Inc. (New Hampshire)
- MEARS Technologies, Inc. (Massachusetts)
- Music Icon, Inc. (New York)
- Nephromics, LLC (Massachusetts)
Andover Venture Fund II | OneVentures Innovation Fund
- IIF Licence | $20m Commonwealth Investment | $20m Private Investor Commitment
- Apr 2009 Andover Venture Partners merged with OneVentures
- Mar 2010 OneVentures Innovation Fund closed on $40 million of capital commitments
- OneVentures Innovation Fund focuses on making investments in the TIME, Cleantech and Life Sciences sectors
- For further informtion please visit www.one-ventures.com.